• RESEARCH

    Oxaliplatin resistance linked to therapy-induced senescence and palmitic acid metabolism

    Preclinical research identified ADORA1-driven palmitic acid synthesis as a key driver of therapy-induced senescence and oxaliplatin resistance in locally advanced CRC; senolytic treatment restored oxaliplatin sensitivity in lab models. (Oncogene)